Introducing Our First 230+ Speakers

 

 

Key Speakers

Shinya Yamanaka Director and Professor, Center for iPS Cell Research & Application (CiRA) Kyoto University Center for iPS Cell Research & Application (CiRA)

Shinya Yamanaka 
Director and Professor, Center for iPS Cell Research & Application (CiRA) 
Kyoto University

Kathy High President and Head, Research & Development Spark Therapeutics Spark Therapeutics Kathy High 
President and Head, Research & Development 
Spark Therapeutics

Dr James Miskin Chief Technical Officer Oxford BioMedica Oxford BioMedica Dr James Miskin 
Chief Technical Officer 
Oxford BioMedica

Andrew Obenshain Head Of Europe Bluebird Bio Bluebird Bio Andrew Obenshain 
Head Of Europe 
Bluebird Bio

Dr Andre Choulika Chairman & Chief Executive Officer Cellectis Cellectis Dr Andre Choulika 
Chairman & Chief Executive Officer 
Cellectis

Alan Smith Executive Vice President, Technical Operations Bellicum Pharmaceuticals Bellicum Pharmaceuticals Alan Smith 
Executive Vice President, Technical Operations 
Bellicum     Pharmaceuticals

Bob Smith Senior Vice President, Global Gene Therapy Business Pfizer Pfizer Bob Smith 
Senior Vice President, Global Gene Therapy Business 
Pfizer

Dr Joanne Kurtzberg Director Carolinas Cord Blood Bank At Duke Carolinas Cord Blood Bank At Duke Dr Joanne Kurtzberg 
Director 
Carolinas Cord Blood Bank At Duke

Dr Roy Baynes SVP & Head Global Clinical Development, Chief Medical Officer Merck Sharp and Dohme (MSD) Merck Sharp and Dohme (MSD) Dr Roy Baynes 
SVP & Head Global Clinical Development, Chief Medical Officer 
Merck Sharp and Dohme (MSD)

Derek Jantz, Co-founder and CSO, Precision BioSciences Precision BioSciences Derek Jantz 
Co-founder and CSO
Precision BioSciences

Lothar Germeroth, SVP, Managing Director, Juno Therapeutics, a Celgene Company Juno Therapeutics, a Celgene Company Lothar Germeroth
SVP, Managing Director
Juno Therapeutics, a Celgene Company

Stephan Grupp, Director of Translational Research, The Children's Hospital of Philadelphia The Children's Hospital of Philadelphia Stephan Grupp
Director of Translational Research
The Children's Hospital of Philadelphia

Fred Chereau, President and CEO, Logic Biotherapeutics Logic Biotherapeutics Fred Chereau 
President and CEO
Logic Biotherapeutics

Edward Rebar, Senior Vice President And Chief Technology Officer, Sangamo Therapeutics Sangamo Therapeutics Edward Rebar
Senior Vice President And Chief Technology Officer
Sangamo Therapeutics

 
 
 

Mayur Abhaya, Managing Director And Chief Executive Officer, Lifecell Ltd

Mayur Abhaya | Managing Director And Chief Executive Officer | Lifecell Ltd » speaking at Advanced Therapies

Mohamed Abou El Enein, Head Of Department, Charite Universitatsmedizin

Mohamed Abou El Enein | Head Of Department | Charite Universitatsmedizin » speaking at Advanced Therapies

Kathrin Adlkofer, Chief Executive Officer, Cellbox Solutions

Sean Ainsworth, Chief Executive Officer And Chairman, Immusoft Corporation

Sean Ainsworth | Chief Executive Officer And Chairman | Immusoft Corporation » speaking at Advanced Therapies

Pinar Akcakaya, Senior Research Scientist, AstraZeneca

Pinar Akcakaya | Senior Research Scientist | AstraZeneca » speaking at Advanced Therapies

Evren Alici, Assistant Professor And Group Leader, Haematology, Karolinska Institutet

Omar Aljitawi, Associate Professor, University of Rochester Medical Center

Eric Alton, Professor Of Gene Therapy And Respiratory Medicine, Faculty of Medicine National Heart and Lung Institute Imperial College London

Jane Andrews, Senior Director Of Strategic Marketing, BioBridge Global

Diego Ardigo, Research And Development Rare Diseases Unit Head, Chiesi Farmaceutici SpA

Stephen Badylak, Deputy Director, Mcgowan Institute For Regenerative Medicine, University of Pittsburgh

Tomasz Baran, Board Member, PBKM/FamiCord Group

Tomasz Baran | Board Member | PBKM/FamiCord Group » speaking at Advanced Therapies

Jacqueline Barry, Chief Clinical Officer, Cell and Gene Therapy Catapult

Frank Barry, Scientific Director, Regenerative Medicine Institute

Frank Barry | Scientific Director | Regenerative Medicine Institute » speaking at Advanced Therapies

Shirley Bartido, Director Of Regulatory Affairs, Cellectis

Adi Barzel, Senior Lecturer, Tel Aviv University

Dr Roy Baynes, Senior Vice President And Head Global Clinical Development, Chief Medical Officer, Merck Sharp and Dohme (MSD)

Robert Beckman, Managing Partner, The Channel Group, LLC

Robert Beckman | Managing Partner | The Channel Group, LLC » speaking at Advanced Therapies

Hanna BERTHAG, European Sales Director, Cellink

Tim Bertram, Chief Executive Officer, inRegen

Martin Birchall, Professor Of Laryngology, UCL

Jaap Boelens, Chief; Stem Cell Transplantation And Cellular Therapies Pediatrics, Memorial Sloan-Kettering Cancer Center

Cristiana Boi, Researcher, University of Bologna

Luc Boileau, Président-Directeur General, Inesss

Luc Boileau | Président-Directeur General | Inesss » speaking at Advanced Therapies

Thomas Bollenbach, Chief Technology Officer, Advanced Regenerative Manufacturing Institute

Thomas Bollenbach | Chief Technology Officer | Advanced Regenerative Manufacturing Institute » speaking at Advanced Therapies

Chris Bond, Director, Future Health Biobank

Chris Bond | Director | Future Health Biobank » speaking at Advanced Therapies

Greg Bonfiglio, Managing Partner, Proteus Venture Partners

Brian Bronk, Head of Business Development, Rare Diseases & Rare Blood Disorders, Global Business Development & Licensing, Sanofi

Didier Caizergues, Director of Regulatory Affairs, Genethon

John Campbell, Associate Director, Tissues, Cells & Advanced Therapeutics, Scottish National Blood Transfusion Service

Susana Cantero Peral, Associate Consultant, Mayo Clinic

Kevin Carrick, Director, Science, Standards And Global Biologics, United States Pharmacopeia

Kevin Carrick | Director, Science, Standards And Global Biologics | United States Pharmacopeia » speaking at Advanced Therapies

Manuel Carrondo, Prof, iBET: Instituto de Biologia Experimental e Tecnológica

Ben Carter, Chief Technology Officer, CytoSeek

Paul Carter, Cell & Gene Therapy Platform CMC, GlaxoSmithKline

Paul Carter | Cell & Gene Therapy Platform CMC | GlaxoSmithKline » speaking at Advanced Therapies

Benoit Champluvier, Chief Technology And Manufacturing Officer, Bone Therapeutics

Benoit Champluvier | Chief Technology And Manufacturing Officer | Bone Therapeutics » speaking at Advanced Therapies

Haifeng Chen, Chief Executive Officer, Virovek

Frederic Chereau, Chief Executive Officer, LogicBio Therapeutics

Dr Yen Choo, Chief Executive Officer, Progenitor Therapeutics

Dr Andre Choulika, Chairman And Chief Executive Officer, Cellectis

Jean-Philippe Combal, Co-founder & CEO, Vivet Therapeutics

Joana Correia, Executive Director And Chief Scientific Officer, Exogenus Therapeutics

David Courtman, Chief Scientific Officer, Northern Therapeutics Inc

Maria Craig, Professor Of Paediatric Endocrinology, University of Sydney

Armando Cuesta Díaz, Partner, Ilana Capital

Danielle Curfs, CEO, Medace

Davide Danovi, Director, Hipsci Cell Phenotyping Programme, King's College London

Francesco Dazzi, Professor Of Regenerative And Hematological Medicine, King's College London

Charles De Cidrac, Director Of Health Insurance, AXA

Charles De Cidrac | Director Of Health Insurance | AXA » speaking at Advanced Therapies

Michèle De Guise, Director of Health Services and Technology Assessment, Inesss

Michèle De Guise | Director of Health Services and Technology Assessment | Inesss » speaking at Advanced Therapies

Carla Deakin, Programme Director – Commercial & Managed Access, NICE

Carla Deakin | Programme Director – Commercial & Managed Access | NICE » speaking at Advanced Therapies

Dr Robert Deans, Chief Technology Officer, Blue Rock Therapeutics

Dr Robert Deans | Chief Technology Officer | Blue Rock Therapeutics » speaking at Advanced Therapies

Graciana Diez-Roux, Chief Scientific Officer, Telethon Institute of Genetics and Medicine

Simone Dimartino, Lecturer, Institute For Bioengineering, University of Edinburgh

Michael Dombeck, Vice President Of Business Development, Precision Biocciences

Jeff Drew, Chief Scientific Officer, Cells4Life Group LLP

Elliot Dunster, Executive Director, Communications, ABPI

Dominik Egger, Research Associate, University of Natural Resources and Life Sciences

Victoria English, Victoria English, Co-founder & Editor, Evernow Publications

Irina Evseeva, Head of Specialist Services, Anthony Nolan

Irina Evseeva | Head of Specialist Services | Anthony Nolan » speaking at Advanced Therapies

Jim Fackler, Associate Professor Of Anesthesiology And Critical Care Medicine, John Hopkins School Of Medicine

Jim Fackler | Associate Professor Of Anesthesiology And Critical Care Medicine | John Hopkins School Of Medicine » speaking at Advanced Therapies

Prof Farzin Farzaneh, Professor Of Molecular Medicine, King's College Hospital NHS Trust

Marcie Finney, Associate Director, Cleveland Cord Blood Center

Lucy Foley, Director Of Biologics, The Centre For Process Innovation (CPI)

Miguel Forte, Chief Executive Officer, Zelluna Immunotherapy

Alberto Sanchez Fueyo, Professor in Hepatology, King's College London

Alberto Sanchez Fueyo | Professor in Hepatology | King's College London » speaking at Advanced Therapies

Michela Gabaldo, Head Of Alliance Management, Fondazione Telethon

Lothar Germeroth, Senior Vice President And Managing Director, Juno Therapeutics GmbH, A Celgene Company

Daniel Gibson, Head Of Innovation And Commercialation, Anthony Nolan

Daniel Gibson | Head Of Innovation And Commercialation | Anthony Nolan » speaking at Advanced Therapies

Janet Glassford, Quality Assessor, MHRA

Sandro Gomez, Investigator Cell & Gene Therapy Platform Process Development R&D, GlaxoSmithKline

Roberto Gramignoli, Professor, Karolinska Institute

Dan Grant, Chief Executive Officer, MTP Connect

Lise Marie Grav, Postdoc, Technical University of Denmark

Adam Gridley, President And Chief Executive Officer, Histogenics Corporation

Uta Griesenbach, Professor Of Molecular Medicine, Imperiai College London

Stephan Grupp, Chief, Cellular Therapy and Transplant Section, The Children's Hospital of Philadelphia

Pascale Guillot, Senior Lecturer Of Fetal And Maternal Health, University College London

Pascale Guillot | Senior Lecturer Of Fetal And Maternal Health | University College London » speaking at Advanced Therapies

Miriam Haak, Manager Business Development, Miltenyi Biotec GmbH

Thomas Hach, Global Brand Medical Director Neuroscience, Novartis

Sam Hall, Principal, Apple Tree Partners

Sam Hall | Principal | Apple Tree Partners » speaking at Advanced Therapies

Joshua Hare, Director Of Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine

Hansjörg Hauser, Head Of Dept. Of Scientific Strategy, Helmholtz Centre for Infection Research GmbH

Frank Hecht, Vice President Marketing And Sales, CellGenix GmbH

Dawn Henke, Senior Technical Program Manager, Standards Coordinating Body

Dawn Henke | Senior Technical Program Manager | Standards Coordinating Body » speaking at Advanced Therapies

Diana Hernandez, Anthony Nolan

Shay Hershcovich, Head Of Business Development, Betalin Therapeutics

Katherine High, M.D., President And Head, Research And Development, Spark Therapeutics

Edward Hodgkin, Partner, Syncona Partners

Karen Hodgkin, Chief Operating Officer, Cell Medica Ltd

Roger Horton, Anthony Nolan Cell Therapy Centre Operational Manager, Anthony Nolan

Michael Hunt, Chief Executive Officer, ReNeuron Group Plc

Giorgio Iotti, Head of Program Leadership and Control, Rare Disease Unit, Chiesi Farmaceutici SpA

Dr Moshe Israeli, Medical Director, Rabin Medical Center

Dr Moshe Israeli | Medical Director | Rabin Medical Center » speaking at Advanced Therapies

Zoran Ivanovic, Scientific Director, French Blood Institute Aquitaine Limousin Branch

Dmitrii Ivolgin, Medical Director, Stem Cells Bank Pokrovski

Agnieszka Janeczek, Interim Ceo, Renovos

Derek Jantz, Co-Founder And Cso, Precision Biosciences

John Johnston, Clinical Assessor, MHRA

Margareth Jorvid, Head of Regulatory Affairs and QA, Immuniucum AB

Margareth Jorvid | Head of Regulatory Affairs and QA | Immuniucum AB » speaking at Advanced Therapies

Ohad Karnieli, CEO, Atvio Biotechnology

Ohad Karnieli | CEO | Atvio Biotechnology » speaking at Advanced Therapies

Cornelia Kasper, Professor, Biopharmaceutical Production And Technology, B.O.K.U.

Hans Keirstead, Chief Executive Officer, AiVita Biomedical

Aisha Khan, Executive Director Of Laboratory Operations, Interdisciplinary Stem Cell Institute

Aisha Khan | Executive Director Of Laboratory Operations | Interdisciplinary Stem Cell Institute » speaking at Advanced Therapies

Sven Kili, Vice President And Head Of Gene Therapy Development, Sven Kili Consulting

Sven Kili | Vice President And Head Of Gene Therapy Development | Sven Kili Consulting » speaking at Advanced Therapies

Gareth King, Manager, Catapult Ventures Group

Gareth King | Manager | Catapult Ventures Group » speaking at Advanced Therapies

Takashi Kei Kishimoto, Chief Science Officer, Selecta Biosciences Inc

Jim Kovach, Director, Innovation

Daniel Kraft, Faculty Chair For Medicine And Neuroscience, Singularity University

Dr Joanne Kurtzberg, Director, Carolinas Cord Blood Bank At Duke

Dr Joanne Kurtzberg | Director | Carolinas Cord Blood Bank At Duke » speaking at Advanced Therapies

Jeffrey L Kutok, Chief Scientific Officer, Infinity Pharmaceuticals, Inc

Dmitry Kuzmin, Managing Partner, 4Bio Capital

Jean-Pierre Latere, Chief Operating Officer, Celyad

Katarina Le Blanc, Professor/Specialist Physician, Division Of Clinical Immunology, Karolinska Institutet

Katarina Le Blanc | Professor/Specialist Physician, Division Of Clinical Immunology | Karolinska Institutet » speaking at Advanced Therapies

Jane Lebkowski, President, Regenerative Patch Technologies

Chaim Lebovits, Chief Executive Officer, Brainstorm Cell Therapeutics Inc

Michael Leek, Chief Executive Officer, TC BioPharm

Chris Leonforte, Processing and QC Manager, Anthony Nolan

Chris Leonforte | Processing and QC Manager | Anthony Nolan » speaking at Advanced Therapies

Vanda Lopes, Senior Scientist II, R&D, Irvine Scientific

Douglas Losordo, Chief Medical Officer, Caladrius

Douglas Losordo | Chief Medical Officer | Caladrius » speaking at Advanced Therapies

Mark Lowdell, Director Of Cellular Therapy, Royal Free London NHS Foundation Trust

Ross Macdonald, Chief Executive Officer, Cynata Therapeutics Ltd

Ross Macdonald | Chief Executive Officer | Cynata Therapeutics Ltd » speaking at Advanced Therapies

Dr Danilo Maddalo, Laboratory Head, Novartis Institutes for Biomedical Research

John Maher, Chief Scientific Officer, Leucid Bio

John Maher | Chief Scientific Officer | Leucid Bio » speaking at Advanced Therapies

Joerg Mahlich, Head Heor, Janssen Pharmaceutical K.K.

Rachel Manley, Head Of Global Outreach, Save the Cord Foundation

Rachel Manley | Head Of Global Outreach | Save the Cord Foundation » speaking at Advanced Therapies

Marcello Maresca, Associate Director, Astrazeneca Ab

Dr Irene Martini, Lecturer, University La Sapienza

Dr Irene Martini | Lecturer | University La Sapienza » speaking at Advanced Therapies

Irene Mavroudi, Researcher, Public Cord Blood Bank of Crete

Giuseppe Mazza, Chief Executive And Scientific Officer, Engitix

David Mazzo, Chief Executive Officer, Caladrius Biosciences

Richard McFarland, Chief Regulatory Officer, Advanced Regenerative Manufacturing Institute

Richard McFarland | Chief Regulatory Officer | Advanced Regenerative Manufacturing Institute » speaking at Advanced Therapies

Ian Mckay, Innovation Lead Advanced Therapies, Innovate UK

Ian Mckay | Innovation Lead Advanced Therapies | Innovate UK » speaking at Advanced Therapies

Nick Medcalf, Innovation Lead - Advanced Therapies, Innovate UK

Nick Medcalf | Innovation Lead - Advanced Therapies | Innovate UK » speaking at Advanced Therapies

Stefano Menegatti, Assistant Professor In Chemical And Biomolecular Engineering, North Carolina State University

Stefano Menegatti | Assistant Professor In Chemical And Biomolecular Engineering | North Carolina State University » speaking at Advanced Therapies

Annamaria Merico, Head Of Technology Transfer, Fondazione Telethon

Annamaria Merico | Head Of Technology Transfer | Fondazione Telethon » speaking at Advanced Therapies

Joanna Miller, Chief Scientific Officer, Cell Therapy Sciences

Joanna Miller | Chief Scientific Officer | Cell Therapy Sciences » speaking at Advanced Therapies

Brian Miller, Chief Executive Officer, Sentien Biotechnology

Dr James Miskin, Chief Technical Officer, Oxford BioMedica

Claudia Mitchell, Chief Operations Officer, Universal Cells

Fabien Moncaubeig, Chief Operating Officer, TreeFrog Therapeutics

Neill Moray Mackenzie, Chairman And Board Mamber, Cellular Therapeutics Ltd

Neill Moray Mackenzie | Chairman And Board Mamber | Cellular Therapeutics Ltd » speaking at Advanced Therapies

David Morrow, Project Manager, EATRIS

Artin Moussavi, Chief Business Officer, TC BioPharm

Thomas Mueller, Head Of Directorate General 1 "Drugs, Medical Devices, Biotechnology", Federal Ministry of Health Germany

Thomas Mueller, Head Of Directorate General 1 "Drugs, Medical Devices, Biotechnology", Federal Ministry of Health Germany

Alan Muir, Director And Co-Founder, Seven Hills Venture Partners

Alan Muir | Director And Co-Founder | Seven Hills Venture Partners » speaking at Advanced Therapies

Sue Mundy, Head Of Cord Blood Collection, Anthony Nolan

Mary Murphy, Principle Investigator, Remedi National University of Ireland Galway

Mary Murphy | Principle Investigator | Remedi National University of Ireland Galway » speaking at Advanced Therapies

Gopalan Narayanan, Vice President, Complex Bio, Voisin Consulting Life Sciences (VCLS)

Alexander Natz, Secretary General, EUCOPE

Goran Nenadic, Group Leader, The Farr Institute’s Health eResearch Centre

Goran Nenadic | Group Leader | The Farr Institute’s Health eResearch Centre » speaking at Advanced Therapies

Andrew Obenshain, Head Of Europe, Bluebird Bio

Jelena Ochs, Manager Business Unit Life Sciences Engineering, Fraunhofer Institute for Production Technology

Eduardo Olavarria, BMT Program Director, Consultant Haematologist, Imperial College Healthcare Nhs Trust

Nneka Onwudiwe, Founder and Chief Executive Officer, Pharmacoeconomics Consultants of America

Dominic O'Reagan, Director And Investor, New Mosaic

Felicia Pagliuca, Co-Founder And Vice President Cell Biology Research and Development, Semma Therapeutics

Helen Papadaki, Professor Of Haematology, School Of Medicine, University Of Crete, Head Of The Department Of Haematology, Public Cord Blood Bank of Crete

Ioannis Papantoniou, Atmp Bioprocessing Coordinator, KU Leuven

Ioannis Papantoniou | Atmp Bioprocessing Coordinator | KU Leuven » speaking at Advanced Therapies

Guy Parkes, Head Of Stem Cell Donation, N.H.S. Blood and Transplant

Detlev Parow, Head Pharmaceutical Department, D.A.K.

Vivienne Parry, Head Of Engagement, Genomics England

Vivienne Parry | Head Of Engagement | Genomics England » speaking at Advanced Therapies

David Pauza, Chief Science Officer, American Gene Technologies International Inc.

Amnon Pelz, Chief Executive Officer, Taburit

Amnon Pelz | Chief Executive Officer | Taburit » speaking at Advanced Therapies

Andy Peniket, Consultant, Haematologist and Bone Marrow Transplant Physician, NIHR Oxford Biomedical Research Centre

Andy Peniket | Consultant, Haematologist and Bone Marrow Transplant Physician | NIHR Oxford Biomedical Research Centre » speaking at Advanced Therapies

Adam Perriman, Lecturer, University of Bristol

Sergey Piletsky, Professor, University of Leicester

Sergey Piletsky | Professor | University of Leicester » speaking at Advanced Therapies

Govind Pindoria, Director Of Venture Support Unit, Imperial Innovations

Dr Nicolas Pineault, Development Scientist, Canadian Blood Services

Sarah Pitluck, Head, Global Pricing And Reimbursement, Spark Therapeutics

Jack Price, Head of Advanced Therapies, National Institute for Biological Standards and Control

Sarah Haywood Price, Chief Executive Officer, MedCity

Dr Qasim Rafiq, Associate Professor, Bioprocessing Of Cell And Gene Therapies, University College London

Dr Qasim Rafiq | Associate Professor, Bioprocessing Of Cell And Gene Therapies | University College London » speaking at Advanced Therapies

Kavita Raj, Consultant Haematologist, Guy's And St Thomas' Hospital

Kavita Raj | Consultant Haematologist | Guy's And St Thomas' Hospital » speaking at Advanced Therapies

Nasir M Rajpoot, Head, AI for Cellular Pathology,, University of Warwick

Lior Raviv, Vice President Of Development, Pluristem

Edward Rebar, Senior Vice President And Chief Technology Officer, Sangamo Therapeutics

Antonio Regalado, Senior Editor, M.I.T. Technology Review

Antonio Regalado | Senior Editor | M.I.T. Technology Review » speaking at Advanced Therapies

Ajan Reginald, Chief Executive Officer, Celixir

Katy Rezvani, Chief, Section Of Cellular Therapy, MD Anderson Cancer Center

Katy Rezvani | Chief, Section Of Cellular Therapy | MD Anderson Cancer Center » speaking at Advanced Therapies

Albert Ribickas, BMT/QC Laboratories Manager, Cell Therapies Facility, Moffitt Cancer Center

Mike Rice, Principal, Defined Health

Rodney Rietze, Lead Cgmp Process Automation, Novartis

Dr Barry Rosen, Senior Principal Scientist/Director, AstraZeneca

Jeff Ross, Chief Executive Officer, Miromatrix

Jeff Ross | Chief Executive Officer | Miromatrix » speaking at Advanced Therapies

Joseph Rotino, Vice President, Quality Assurance And Regulatory Affairs, Cryoport Inc

Peter Saltonstall, Chief Executive Officer, National Organization for Rare Disorders (NORD)

Mark Sawicki, Chief Commercial Officer, Cryoport Inc

Machi Scaradavou, Medical Director of the National Cord Blood Program, New York Blood Center

Machi Scaradavou | Medical Director of the National Cord Blood Program | New York Blood Center » speaking at Advanced Therapies

Julia Schaft, Managing Director, BioRN

Manfred Schmidt, Shareholder And Chief Executive Officer, GeneWerk

Dominic Schmidt, Partner, Syncona Investment Management Ltd

Katja Schmidt, Head of Market Access and Public Affairs, Novartis

Katja Schmidt | Head of Market Access and Public Affairs | Novartis » speaking at Advanced Therapies

Maria Schöpe, Deputy Head of Production, Vita34

Maria Schöpe | Deputy Head of Production | Vita34 » speaking at Advanced Therapies

Maria Schöpe, Deputy Head of Production, Vita34

Angela Scott, Chief Operating Officer, TC BioPharm

Angela Scott | Chief Operating Officer | TC BioPharm » speaking at Advanced Therapies

R Session Ii, ‎Senior Vice President of Corporate Strategy & Project Management, 4DMT

R Session Ii | ‎Senior Vice President of Corporate Strategy & Project Management | 4DMT » speaking at Advanced Therapies

Beth Shaz, Chief Medical Officer, New York Blood Center

Jonathan Sheffield, Chief Executive Officer, NIHR Clinical Research Network

Benjamin Shepherd, Associate Director Of Research and Development, Therapeutics, Organovo

Elizabeth Shpall, Director, MD Anderson Cancer Center

Elizabeth Shpall | Director | MD Anderson Cancer Center » speaking at Advanced Therapies

David Sloman, Chief Executive Officer, Royal Free London NHS Foundation Trust

David Sloman | Chief Executive Officer | Royal Free London NHS Foundation Trust » speaking at Advanced Therapies

Devyn Smith, Chief Strategy Officer & Head of Operations, Sigilon

Alan Smith, Executive Vice President, Technical Operations, Bellicum Pharmaceuticals

Bob Smith, Senior Vice President, Global Gene Therapy Business, Pfizer

Rachel Smith, Senior Clinical Project Manager, The Clinical Trial Company Limited

Eric Soller, Vice President Of Corporate Development And Strategy, BlueRock Therapeutics

Susan Solomon, CEO and Founder, The New York Stem Cell Foundation Research Institute

Dr Andrea Spezzi, Chief Medical Officer and Co-founder, Orchard Therapeutics

Mangala Srinivas, Head Of Multiscale Imaging Lab, Radboud University Medical Centre

Dr Glyn Stacey, Executive Director, International Stem Cell Banking Initiative

Michael Stein, Chief Executive Officer, Oxstem

Sanja Stifter, Professor, Department Of Pathology, Faculty Of Medicine, University of Rijeka

Warachaya Sutheesophon, Medical Director, THAI StemLife Co.,Ltd.

Mathias Svahn, Chief Executive Officer, Nextcell Pharma

Stefanos Theoharis, Senior Vice President Of Corporate Development And Partnering, Cell Medica Ltd

Stefanos Theoharis | Senior Vice President Of Corporate Development And Partnering | Cell Medica Ltd » speaking at Advanced Therapies

Robert Thomas, Epsrc Career Fellow, Epsrc Centre For Innovative Manufacturing In Regenerative Medicine, Loughborough University

Dr Frédéric Triebel, Chief Scientific Officer And Medical Officer, Prima Biomed, Ltd

Marc Turner, Medical Director, Scottish National Blood Transfusion Service

Marc Turner | Medical Director | Scottish National Blood Transfusion Service » speaking at Advanced Therapies

Marcos Valadares, Co-Founder, Pluricell

Walter Van Dyck, Associate Professor, Vlerick Healthcare Management Centre

Walter Van Dyck | Associate Professor | Vlerick Healthcare Management Centre » speaking at Advanced Therapies

Alain Vertes, Vice President, Alliance Management, Mesoblast Inc

Alain Vertes | Vice President, Alliance Management | Mesoblast Inc » speaking at Advanced Therapies

Rogerio Vivaldi, Chief Executive Officer, Sigilon Therapeutics

Rogerio Vivaldi | Chief Executive Officer | Sigilon Therapeutics » speaking at Advanced Therapies

Dr Ivan Wall, Reader In Department Of Biochemical Engineering, Aston University

Dr Michael West, Chief Executive Officer, AgeX Therapeutics

Dr Michael West | Chief Executive Officer | AgeX Therapeutics » speaking at Advanced Therapies

Mathew Wheeler, Associate Director Of Europe, VectorBuilder

Bodil Willumsen, Supplier Relationship Manager, External Supply Operations, Cell And Gene Therapy, Novartis

Bodil Willumsen | Supplier Relationship Manager, External Supply Operations, Cell And Gene Therapy | Novartis » speaking at Advanced Therapies

Michal Wlodarski, Principal, Cambridge Innovation Consulting

Fraser Wright, CTO, Axovant Sciences

Fraser Wright | CTO | Axovant Sciences » speaking at Advanced Therapies

David Johannes Wurm, Project Assistant Of Biochemical Engineering, Vienne University of Technology

David Johannes Wurm | Project Assistant Of Biochemical Engineering | Vienne University of Technology » speaking at Advanced Therapies

Shinya Yamanaka, Director And Professor, Center For Ips Cell Research And Application (Cira), Kyoto University

Seppo Yla-Herttuala, Academy Professor, University of Eastern Finland

Seppo Yla-Herttuala | Academy Professor | University of Eastern Finland » speaking at Advanced Therapies

Stefano Zancan, Head Clinical Development And Operations, Fondazione Telethon

Xiaokui Zhang, Chief Scientific Officer, Celularity

 

There are two parts to the World Advanced Therapies & Regenerative Medicine Congress: a conference and an exhibition featuring solutions for pharma and biotech.

There is a registration fee to attend the conferences. To visit the exhibition is free.

TO SPONSOR / EXHIBIT

Erica Baeta 
+44 (0)207 092 1152 
erica.baeta@terrapinn.com

TO SPEAK

Jessica Robinson 
t/ +44 (0)207 092 1150 
jessica.robinson@terrapinn.com

TO REGISTER

Issa Mauthoor 
+44 (0)207 092 1257 
issa.mauthoor@terrapinn.com